Tbi clinical trials

Explore recruiting tbi clinical trials.

Recruiting tbi studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Tbi trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study evaluating the safety and efficacy of once-weekly dosing of somapacitan in a basket study design in paediatric participants with short stature either born small of gestational age or with Turner syndrome, Noonan syndrome or idiopathic short stature

Netherlands, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

(CIAO@TBI) Complement Inhibition: Attacking Overshooting Inflammation @fter traumatic brain injury

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized, Double-Blinded, Vehicle-Controlled, Parallel Group, Adaptive Proof-of-concept, Dose-selecting Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Intranasal Cenegermin (recombinant human Nerve Growth Factor [rhNGF]) in Adult Participants with subacute moderate to severe Traumatic Brain Injury (TBI).

Italy, Denmark, Finland, France, Germany, Spain +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

EFFICACY OF PROPRANOLOL IN TRAUMATIC BRAIN INJURY PATIENTS ADMITTED TO THE ICU: A PROSPECTIVE, RANDOMIZED, TRIPLE-BLIND STUDY (ProP TBI in ICU)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Dexamethasone for the treatment of traumatic brain injured patients with brain contusions and pericontusional edema: Study protocol for a prospective, randomized and double blind trial

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A phase 2a open-label study to assess the safety, tolerability, and dosing regimen of antithrombotic heparin proteoglycan mimetic APAC (antiplatelet, anticoagulant) in patients with peripheral arterial occlusive disease and chronic limb-threatening ischemia undergoing endovascular revascularization (HEALING -study)

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Tbi trials by city

Tbi in Toronto Tbi in Vancouver Tbi in Montreal Tbi in Calgary Tbi in Edmonton Tbi in Ottawa Tbi in Winnipeg Tbi in Quebec City Tbi in Hamilton Tbi in Kitchener Tbi in London Tbi in Halifax Tbi in New York Tbi in Los Angeles Tbi in Chicago Tbi in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease